What's happening to Buffett's Tech investment, IBM?! Check out our Report to see our take on its valuation! HIDE

An Anti-Psychotic Drug With its Own Issues: AstraZeneca’s Seroquel – German Patent Tossed

AstraZeneca’s (AZN) big selling Seroquel, an anti-psychotic drug with annual sales well over $1 billion, suffered the loss of its German patent, according to an AP news dispatch.

The setback comes in the wake of questions about Seroquel’s heavy prescribing by the U.S. military for off-label uses, as YCharts has reported.

AZN Chart

AZN data by YCharts

AstraZeneca has struggled more than most drug makers – more, according to this brilliant Forbes analysis, than Pfizer (PFE), GlaxoSmithKline (GSK), Sanofi (SNY) or Johnson & Johnson (JNJ) -- to develop new drugs and replace those with expiring patents.

From the editors of YCharts, which includes the just-released YCharts Pro Platinum for professional investors.

Read more articles about: Company Analysis  

blog comments powered by Disqus
Advertisement

Search Articles

Subscribe to YCharts Analysis

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.